
Managed by Schroders Capital

Fund Size
€63M
Target Return
9.4%
Annualized Return
0.8%
Launch Year
2021
Min. Investment
€10,000
Availability
Open for public
Structure
Luxembourg SICAV (Part II UCI), sub-fund of Schroders Capital Semi-Liquid
Product Category
Open-end
Domicile
Luxembourg
GP Type
Single
Liquidity Level
Semi-liquid
Management Fee
1.9%
Carry
None%
High Water Mark
No
ISIN
LU2523322431
Currencies
USD
Investor Eligibility
Retail
Liquidity Options
Quarterly redemptions
KID Risk Indicator
4 out of 7
Annual Returns (KID Scenarios)
Stressed
-14%
Moderate
3.78%
Favorable
9.41%
Average Total Cost Level (KID)
4.58%
The venture and growth sleeve of Schroders Capital’s semi-liquid range is the Schroders Capital Semi-Liquid Global Innovation Private Plus fund, a Luxembourg-domiciled SICAV sub-fund launched on 29 October 2021 as Schroder GAIA II Global Innovation Private Plus and rebranded in 2023. The vehicle invests in innovative private companies worldwide with a technology and healthcare bias and a five-to-seven-year horizon to achieve capital growth, through direct investments, co-investment vehicles and secondaries, complemented by a selection of listed equities. The fund is denominated in US dollars.
Net Assets
$63.4M
Semi-annual report, 30 Jun 2025
Since Launch (A Acc)
+2.8%
Cumulative, Oct 2021 – Jun 2025
Management Fee
1.90%
A shares; C 1.45%, E/ID/IE 1.20%
Ongoing Charge (A Acc)
2.49%
KID total cost 4.58% incl. underlying
Liquidity
Quarterly
Redemptions capped at 5% of NAV
Minimum
€10,000
Via distributors
This is a small fund, with net assets of $63.4 million at 30 June 2025. In comparison, its sibling Schroders Capital Semi-Liquid Global Private Equity has around $2.2 billion. The direct portfolio is recognisably AI-heavy: Synthesia (6.6% of NAV), Poolside (4.7%), Hound Technology (4.2%), Securiti (4.0%), Uniphore (3.4%) and Scale AI (2.7%), alongside the biotech names iOnctura, Memo Therapeutics and Neurona. A third of the portfolio consists of investee funds and co-investment vehicles, and a very notable 29% was sitting in money-market funds at the reporting date, which dilutes returns until it is deployed. The geographical split is roughly two-thirds North America, a quarter Europe and the remainder Asia.
| Synthesia | 6.6% — AI video generation (UK) |
| Poolside | 4.7% — AI coding models (US) |
| Hound Technology | 4.2% — Software (US) |
| Securiti | 4.0% — Data security & AI governance (US) |
| Uniphore | 3.4% — Conversational AI (US) |
| Scale AI | 2.7% — AI data infrastructure (US) |
| Biotech | iOnctura (CH), Memo Therapeutics (CH), Neurona Therapeutics (US) |
| Investee funds & co-invest vehicles | 32% of NAV (incl. Lakefront, Vega Co-Invest, Chronos Capital, Sprints Capital Ellison) |
| Liquidity funds | 29% of NAV (Goldman Sachs, Morgan Stanley, Deutsche money-market funds) |
Management fees are 1.90% a year for the A shares, 1.45% for the C shares and 1.20% for the E, ID and IE institutional classes; the ongoing charge for Class A Acc was 2.49% in the latest semi-annual report, and the KID’s total cost figure comes to 4.58% once underlying fund and transaction costs are counted. The fund is offered as a semi-liquid product: redemptions are possible on a quarterly basis up to a maximum of 5% of NAV. It sits in KID risk class 4 of 7 with a moderate scenario of 3.8% and a favourable scenario of 9.4% a year — but the record so far is thin: Class A Acc had returned a cumulative 2.8% since launch by 30 June 2025, with several hedged classes negative. The minimum subscription is €10,000 via distributors.
More funds like this
This is an unverified fund profile written by FundScouter and may contain inaccuracies.
Are you affiliated with this fund? Claim this fund to verify and manage your fund profile.